| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 975,600 | 1,019,900 | 992,600 | 1,030,200 | | Cost of Revenue | 249,300 | 236,800 | 230,300 | 243,100 | | | Gross Profit | 726,300 | 783,100 | 762,300 | 787,100 | | | Operating Expenses | | Research Development | 52,100 | 49,900 | 51,800 | 47,200 | | Selling General and Administrative | 1,939,400 | 425,300 | 430,700 | 435,600 | | Non Recurring | 54,300 | 11,400 |
-
| 64,600 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 204,000 | 296,500 | 279,800 | 239,700 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| (4,200) | | Earnings Before Interest And Taxes | 192,100 | 296,500 | 279,800 | 235,500 | | Interest Expense | (7,700) | 4,000 | 3,700 |
-
| | Income Before Tax | 199,800 | 292,500 | 276,100 | 235,500 | | Income Tax Expense | 49,900 | 82,400 | 73,900 | 67,900 | | Minority Interest |
-
|
-
|
-
| (100) | | | | Net Income From Continuing Ops | 149,900 | 210,100 | 202,200 | 167,500 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 149,900 | 210,100 | 202,200 | 167,500 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $149,900 | $210,100 | $202,200 | $167,500 |
|
0.51% Nasdaq 
Income Statement
